Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), and Region - Global Forecast to 2027

Abstract
The global home healthcare market is projected to reach USD 340.2 Billion by 2027 from USD 226.0 Billion in 2022, at a CAGR of 8.5% during the forecast period Growth in this market is mainly driven by the technological advancements in home healthcare products and services.

"The therapeutic products segment accounted for the highest growth rate in the home healthcare market, by product, during the forecast period."

The home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products based on product. In 2021, the therapeutic products segment accounted for the highest growth rate in the home healthcare market. Market growth can largely be attributed to growing prevalence of chronic diseases.

"Infusion therapy services segment accounted for the highest CAGR."

Based on the services, the home healthcare market has been segmented into skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. In 2021, the skilled nursing services segment accounted for the highest growth rate. This can be attributed to the rising population and urbanization.

"Asia Pacific: The fastest-growing region home healthcare market."

The global home healthcare market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as initiatives by government to promote home healthcare, and higher healthcare costs.

The primary interviews conducted for this report can be categorized as follows:
•By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
•By Designation: C-level - 27%, D-level - 18%, and Others - 55%
•By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:
•Fresenius SE & Co. KGaA (Germany)
•Linde, Plc (Ireland)
•F.Hoffmann-La Roche, Ltd. (Switzerland)
•A&D Company, Limited (Japan)
•Bayada Home Health Care (US)
•Invacare Corporation (US)
•Abbott (US)
•Amedisys (US)
•ResMed, Inc. (US)
•LHC Group, Inc. (US)
•Omron Corporation (Japan)
•Koninkluke Philips N.V. (Netherlands)
•GE Healthcare (US)
•Drive Devilbiss Healthcare (UK)
•Hamilton Medical (Switzerland)
•Sunrise Medical (Germany)
•Roma Medical (UK)
•Caremax Rehabilitation Equipment Co., Ltd. (China)
•Vitalograph (UK)
•Advita Pflegedienst Gmbh (Germany)
•Renafan Gmbh (Germany)
•ADMR (France)
•Apex Medical Corp. (Taiwan)
•Contec Medical Systems Co., Ltd. (China)
•Löwenstein Medical Technology Gmbh + Co., KG. (Germany)
•B. Braun Melsungen Ag (Germany)
•Baxter International, Inc. (US)
•Allied Healthcare Products, Inc. (US)
•Medline Industries, Inc. (US)
•Advin Health Care (India)

Research Coverage:
This report provides a detailed picture of the global home healthcare market. It aims at estimating the size and future growth potential of the market across different segments, such as product, service, indication, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall home healthcare market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

Content
Table of Contents

1INTRODUCTION34
1.1STUDY OBJECTIVES34
1.2MARKET DEFINITION34
TABLE 1INCLUSIONS AND EXCLUSIONS34
1.3STUDY SCOPE35
1.4YEARS CONSIDERED36
1.5CURRENCY CONSIDERED36
1.6STAKEHOLDERS36
1.7SUMMARY OF CHANGES37
1.8LIMITATIONS38
2RESEARCH METHODOLOGY39
2.1RESEARCH DATA39
FIGURE 1HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY39
2.1.1SECONDARY DATA39
2.1.1.1Secondary sources41
2.1.2PRIMARY DATA41
TABLE 2KEY DATA FROM PRIMARY SOURCES42
FIGURE 2KEY INDUSTRY INSIGHTS43
2.1.2.1Breakdown of primary interviews43
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HOME HEALTHCARE MARKET)43
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION44
2.2MARKET SIZE ESTIMATION44
2.2.1BOTTOM-UP APPROACH45
FIGURE 5BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH45
FIGURE 6REVENUE SHARE ANALYSIS ILLUSTRATION: F. HOFFMANN-LA ROCHE LTD.46
2.2.1.1Growth forecast46
2.2.1.2CAGR projections47
FIGURE 7CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS47
2.2.2TOP-DOWN APPROACH47
FIGURE 8HOME HEALTHCARE MARKET: TOP-DOWN APPROACH47
2.3MARKET BREAKDOWN AND DATA TRIANGULATION48
FIGURE 9DATA TRIANGULATION METHODOLOGY48
2.4MARKET SHARE ANALYSIS49
2.5STUDY ASSUMPTIONS49
2.6RISK ASSESSMENT49
 
3EXECUTIVE SUMMARY50
FIGURE 10HOME HEALTHCARE MARKET, BY TYPE, 2022 VS. 2027 (USD BILLION)50
FIGURE 11HOME HEALTHCARE MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)51
FIGURE 12HOME HEALTHCARE MARKET, BY SERVICE, 2022 VS. 2027 (USD BILLION)51
FIGURE 13HOME HEALTHCARE MARKET, BY INDICATION, 2022 VS. 2027 (USD BILLION)52
FIGURE 14GEOGRAPHICAL SNAPSHOT OF HOME HEALTHCARE MARKET53
4PREMIUM INSIGHTS54
4.1HOME HEALTHCARE MARKET OVERVIEW54
FIGURE 15GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD54
4.2ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT (2021)55
FIGURE 16THERAPEUTIC PRODUCTS ACCOUNTED FOR LARGEST MARKET SHARE55
4.3GEOGRAPHIC GROWTH OPPORTUNITIES IN HOME HEALTHCARE MARKET56
FIGURE 17JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD56
4.4HOME HEALTHCARE MARKET: GEOGRAPHIC MIX56
FIGURE 18APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD56
4.5HOME HEALTHCARE MARKET: DEVELOPED VS. EMERGING ECONOMIES57
FIGURE 19DEVELOPING MARKETS TO REGISTER HIGHER GROWTH57
5MARKET OVERVIEW58
5.1INTRODUCTION58
5.2MARKET DYNAMICS58
FIGURE 20HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES58
5.2.1DRIVERS59
5.2.1.1Rapid growth in elderly population and rising incidence of chronic diseases59
TABLE 3GERIATRIC POPULATION, 2022 VS. 2050 (MILLION)59
5.2.1.2Rising R&D investments60
TABLE 4PRODUCT LAUNCHES60
5.2.1.3Growing need for cost-effective healthcare delivery due to rising costs61
5.2.1.4Increased preference for personalized care61
5.2.2RESTRAINTS61
5.2.2.1Changing reimbursement policies61
5.2.2.2Limited insurance coverage62
5.2.2.3Patient safety concerns63
5.2.3OPPORTUNITIES63
5.2.3.1Rising focus on telehealth63
5.2.3.2Untapped developing regions64
5.2.3.3Growing demand for home-use therapeutic devices64
5.2.3.4Growing demand for home sleep apnea tests65
5.2.3.5Rising preference for home hemodialysis treatment66
5.2.4CHALLENGES66
5.2.4.1Shortage of home care workers66
5.2.4.2Lack of supporting infrastructure67
5.3PRICING ANALYSIS68
TABLE 5AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2022)68
TABLE 6AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS (2022)68
5.4PATENT ANALYSIS72
5.4.1PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES72
5.4.1.1Granted patent publication trends for temperature monitoring devices72
FIGURE 21PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2021)72
5.4.1.2Insights: Jurisdiction and top applicant analysis73
FIGURE 22TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR TEMPERATURE MONITORING DEVICES (JANUARY 2012–DECEMBER 2021)73
FIGURE 23TOP PATENT APPLICANT COUNTRIES/REGIONS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2012–DECEMBER 2021)74
FIGURE 24PATENT ANALYSIS FOR THERMOMETERS (JANUARY 2012–DECEMBER 2021)74
5.4.2LIST OF KEY PATENTS75
5.5VALUE CHAIN ANALYSIS76
FIGURE 25VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES76
5.6SUPPLY CHAIN ANALYSIS77
FIGURE 26HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS78
5.7ECOSYSTEM/MARKET MAP78
FIGURE 27HOME HEALTHCARE MARKET: ECOSYSTEM/MARKET MAP79
5.7.1HOME HEALTHCARE MARKET: ROLE IN ECOSYSTEM79
5.8PORTER’S FIVE FORCES ANALYSIS80
5.8.1PULSE OXIMETERS80
TABLE 7PORTER’S FIVE FORCES ANALYSIS FOR THE PULSE OXIMETERS MARKET80
5.8.1.1Threat of new entrants80
5.8.1.2Threat of substitutes81
5.8.1.3Bargaining power of suppliers81
5.8.1.4Bargaining power of buyers81
5.8.1.5Degree of competition81
5.8.2HEARING AIDS82
TABLE 8PORTER’S FIVE FORCES ANALYSIS: HEARING AIDS MARKET82
5.8.2.1Threat of new entrants82
5.8.2.2Threat of substitutes82
5.8.2.3Bargaining power of buyers82
5.8.2.4Bargaining power of suppliers82
5.8.2.5Degree of competition82
 
5.9REGULATORY LANDSCAPE83
TABLE 9NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS83
TABLE 10EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS83
TABLE 11ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS84
TABLE 12LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS84
TABLE 13ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS84
5.9.1NORTH AMERICA85
5.9.1.1US85
TABLE 14US FDA: CLASSIFICATION OF MEDICAL DEVICES85
TABLE 15US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS86
FIGURE 28PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES86
5.9.1.2Canada86
TABLE 16CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS86
FIGURE 29APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA87
5.9.2EUROPE87
FIGURE 30CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES88
5.9.3ASIA PACIFIC88
5.9.3.1Japan88
TABLE 17JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES89
5.9.3.2China89
TABLE 18CHINA: CLASSIFICATION OF MEDICAL DEVICES90
5.9.3.3India91
5.10TRADE ANALYSIS92
5.10.1TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS92
TABLE 19IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY,
2017–2021 (USD MILLION)92
TABLE 20EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY,
2017–2021 (USD MILLION)92
5.11TECHNOLOGY ANALYSIS93
5.12KEY CONFERENCES & EVENTS IN 2022–202394
TABLE 21HOME HEALTHCARE MARKET: CONFERENCES & EVENTS94
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES95
FIGURE 31REVENUE SHIFT IN HOME HEALTHCARE95
5.14KEY STAKEHOLDERS & BUYING CRITERIA96
5.14.1KEY STAKEHOLDERS IN BUYING PROCESS96
FIGURE 32INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS96
TABLE 22INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS96
 
5.14.2BUYING CRITERIA97
FIGURE 33KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS97
TABLE 23KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS97
6HOME HEALTHCARE MARKET, BY PRODUCT98
6.1INTRODUCTION99
TABLE 24HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD BILLION)99
6.2THERAPEUTIC PRODUCTS100
TABLE 25KEY THERAPEUTIC PRODUCTS OFFERED100
TABLE 26THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD BILLION)101
TABLE 27THERAPEUTIC PRODUCTS MARKET, BY REGION, 2020–2027 (USD BILLION)101
6.2.1DIALYSIS EQUIPMENT102
6.2.1.1Dialysis equipment to hold largest market share102
TABLE 28DIALYSIS EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)103
6.2.2WOUND CARE PRODUCTS103
6.2.2.1Decreased costs and higher convenience and comfort to drive market growth103
TABLE 29WOUND CARE PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)104
6.2.3IV EQUIPMENT104
6.2.3.1Accuracy and growing target disease prevalence to ensure market growth104
TABLE 30IV EQUIPMENT MARKET, BY REGION, 2020–2027 (USD MILLION)105
6.2.4SLEEP APNEA THERAPEUTIC DEVICES105
6.2.4.1Increasing patient preference for home-based sleep tests to fuel market105
TABLE 31SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)106
6.2.5INSULIN DELIVERY DEVICES106
6.2.5.1High incidence of diabetes to drive market106
TABLE 32INSULIN DELIVERY DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)106
6.2.6OXYGEN DELIVERY SYSTEMS107
6.2.6.1Technological advancements in oxygen therapy products to drive market107
TABLE 33OXYGEN DELIVERY SYSTEMS MARKET, BY REGION,
2020–2027 (USD MILLION)107
6.2.7INHALERS107
6.2.7.1High incidence of asthma to boost market107
TABLE 34INHALERS MARKET, BY REGION, 2020–2027 (USD MILLION)108
6.2.8NEBULIZERS108
6.2.8.1Effectiveness over oral dosages to push preference for nebulizers108
TABLE 35NEBULIZERS MARKET, BY REGION, 2020–2027 (USD MILLION)109
6.2.9VENTILATORS109
6.2.9.1Convenience and comfort to sustain end-user preference109
TABLE 36VENTILATORS MARKET, BY REGION, 2020–2027 (USD MILLION)110
6.2.10OTHER THERAPEUTIC PRODUCTS110
TABLE 37OTHER THERAPEUTIC PRODUCTS, BY REGION, 2020–2027 (USD MILLION)110
6.3TESTING, SCREENING, AND MONITORING PRODUCTS111
TABLE 38KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED111
TABLE 39TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 40TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)113
6.3.1BLOOD GLUCOSE MONITORS113
6.3.1.1Increasing prevalence of diabetes to drive market growth113
TABLE 41BLOOD GLUCOSE MONITORS MARKET, BY REGION,
2020–2027 (USD MILLION)114
6.3.2HEARING AIDS114
6.3.2.1High incidence of hearing impairment to drive market114
TABLE 42HEARING AIDS MARKET, BY REGION, 2020–2027 (USD MILLION)115
6.3.3ACTIVITY MONITORS & WRISTBANDS115
6.3.3.1Increasing prevalence of chronic diseases to bolster demand for activity monitors115
TABLE 43ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION,
2020–2027 (USD MILLION)115
6.3.4BLOOD PRESSURE MONITORS116
6.3.4.1Rising patient population for hypertension and CVD to drive market116
TABLE 44BLOOD PRESSURE MONITORS MARKET, BY REGION,
2020–2027 (USD MILLION)116
6.3.5ECG/EKG DEVICES117
6.3.5.1High prevalence of CVD to support demand117
TABLE 45ECG/EKG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)117
6.3.6TEMPERATURE MONITORING DEVICES118
6.3.6.1Technological innovations and increasing awareness to drive growth118
TABLE 46TEMPERATURE MONITORING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)118
6.3.7HEART RATE MONITORS119
6.3.7.1Continuous cardiac parameter monitoring capabilities to drive demand119
TABLE 47HEART RATE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)119
6.3.8OVULATION & PREGNANCY TEST KITS119
6.3.8.1Privacy, convenience, accessibility, and quick results to drive market119
TABLE 48OVULATION & PREGNANCY TEST KITS MARKET, BY REGION,
2020–2027 (USD MILLION)120
6.3.9FETAL MONITORING DEVICES120
6.3.9.1Remote-based care by portable fetal monitoring systems to drive market growth120
TABLE 49FETAL MONITORING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)121
6.3.10PULSE OXIMETERS121
6.3.10.1Rising disease incidence and wide usage of pulse oximetry to ensure strong demand121
TABLE 50PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)122
6.3.11HIV TEST KITS122
6.3.11.1Rising prevalence of HIV to drive market122
TABLE 51HIV TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION)122
6.3.12HOLTER & EVENT MONITORS123
6.3.12.1Rising awareness of preventive care and technological advancements to drive market123
TABLE 52HOLTER & EVENT MONITORS MARKET, BY REGION,
2020–2027 (USD MILLION)123
6.3.13DRUG & ALCOHOL TEST KITS123
6.3.13.1Rising consumption of drugs among teens to support market growth123
TABLE 53DRUG & ALCOHOL TEST KITS MARKET, BY REGION,
2020–2027 (USD MILLION)124
6.3.14COAGULATION MONITORING PRODUCTS124
6.3.14.1Rising use of anticoagulant therapy and availability of home-use kits to drive market124
TABLE 54COAGULATION MONITORING PRODUCTS MARKET, BY REGION,
2020–2027 (USD MILLION)125
6.3.15PEAK FLOW METERS125
6.3.15.1High portability and cost-efficiency to ensure adoption125
TABLE 55PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION)126
6.3.16COLON CANCER TEST KITS126
6.3.16.1High incidence of colorectal cancer to drive market growth126
TABLE 56COLON CANCER TEST KITS MARKET, BY REGION, 2020–2027 (USD MILLION)126
6.3.17HOME SLEEP TESTING DEVICES127
6.3.17.1Cost-effectiveness of home-based sleep tests to fuel growth127
TABLE 57HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION)128
6.3.18EEG DEVICES128
6.3.18.1Wide patient population for epilepsy to drive market for EEG devices128
TABLE 58EEG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)128
6.3.19CHOLESTEROL TESTING PRODUCTS129
6.3.19.1Rising obesity levels and CVD incidence to support market129
TABLE 59CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION,
2020–2027 (USD MILLION)129
6.3.20HOME HEMOGLOBIN A1C TEST KITS129
6.3.20.1High incidence of diabetes to drive market129
TABLE 60HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION,
2020–2027 (USD MILLION)130
6.4MOBILITY CARE PRODUCTS130
TABLE 61KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET130
TABLE 62MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 63MOBILITY CARE PRODUCTS MARKET, BY REGION,
2020–2027 (USD MILLION)132
6.4.1WHEELCHAIRS132
6.4.1.1Increased preference for wheelchairs to boost demand132
TABLE 64WHEELCHAIRS MARKET, BY REGION, 2020–2027 (USD MILLION)133
6.4.2MOBILITY SCOOTERS133
6.4.2.1High cost to affect end-user adoption133
TABLE 65MOBILITY SCOOTERS MARKET, BY REGION, 2020–2027 (USD MILLION)133
6.4.3WALKERS & ROLLATORS134
6.4.3.1Difficulties in using walkers and availability of alternatives to restrain market134
TABLE 66WALKERS & ROLLATORS MARKET, BY REGION, 2020–2027 (USD MILLION)134
6.4.4CRUTCHES134
6.4.4.1High preference for axilla crutches to support demand134
TABLE 67CRUTCHES MARKET, BY REGION, 2020–2027 (USD MILLION)135
6.4.5CANES135
6.4.5.1Wide usage of canes to drive market135
TABLE 68CANES MARKET, BY REGION, 2020–2027 (USD MILLION)135
7HOME HEALTHCARE MARKET, BY SERVICE136
7.1INTRODUCTION137
TABLE 69HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD BILLION)137
TABLE 70HOME HEALTHCARE SERVICES MARKET, BY REGION,
2020–2027 (USD BILLION)137
7.2SKILLED NURSING SERVICES138
7.2.1SKILLED NURSING SERVICES TO DOMINATE MARKET138
TABLE 71SKILLED NURSING SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION)138
7.3REHABILITATION THERAPY SERVICES138
7.3.1RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND FOR THERAPY138
TABLE 72REHABILITATION THERAPY SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION)139
7.4HOSPICE & PALLIATIVE CARE SERVICES139
7.4.1RISING GERIATRIC POPULATION TO DRIVE HOSPICE & PALLIATIVE CARE SERVICE DEMAND139
TABLE 73HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION)140
7.5UNSKILLED CARE SERVICES140
7.5.1COST-EFFECTIVENESS TO DRIVE GROWTH140
TABLE 74UNSKILLED SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)141
7.6RESPIRATORY THERAPY SERVICES141
7.6.1GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET141
TABLE 75RESPIRATORY THERAPY SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION)142
7.7INFUSION THERAPY SERVICES142
7.7.1SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND142
TABLE 76INFUSION THERAPY SERVICES MARKET, BY REGION,
2020–2027 (USD MILLION)143
7.8PREGNANCY CARE SERVICES143
7.8.1NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH143
TABLE 77PREGNANCY CARE MARKET, BY REGION, 2020–2027 (USD MILLION)144
8HOME HEALTHCARE MARKET, BY INDICATION145
8.1INTRODUCTION146
TABLE 78HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD BILLION)146
TABLE 79HOME HEALTHCARE INDICATIONS MARKET, BY REGION,
2020–2027 (USD BILLION)146
8.2CANCER147
8.2.1CANCER TO DOMINATE INDICATIONS MARKET147
TABLE 80INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)147
TABLE 81HOME HEALTHCARE MARKET FOR CANCER, BY REGION,
2020–2027 (USD MILLION)148
8.3RESPIRATORY DISEASES148
8.3.1RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET148
TABLE 82HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2020–2027 (USD MILLION)149
8.4MOVEMENT DISORDERS149
8.4.1GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT149
TABLE 83HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2020–2027 (USD MILLION)150
8.5CVD & HYPERTENSION150
8.5.1RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH150
TABLE 84HOME HEALTHCARE MARKET FOR CVD & HYPERTENSION, BY REGION,
2020–2027 (USD MILLION)151
8.6PREGNANCY151
8.6.1RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH151
TABLE 85HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION,
2020–2027 (USD MILLION)152
8.7WOUND CARE152
8.7.1GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET GROWTH152
TABLE 86HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION,
2020–2027 (USD MILLION)153
8.8DIABETES153
8.8.1INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH153
TABLE 87HOME HEALTHCARE MARKET FOR DIABETES, BY REGION,
2020–2027 (USD MILLION)154
8.9HEARING DISORDERS154
8.9.1WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH154
TABLE 88HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION,
2020–2027 (USD MILLION)154
8.10OTHER INDICATIONS155
TABLE 89HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION,
2020–2027 (USD MILLION)155
9HOME HEALTHCARE MARKET, BY REGION156
9.1INTRODUCTION157
TABLE 90HOME HEALTHCARE MARKET, BY REGION, 2020–2027 (USD BILLION)157
9.2NORTH AMERICA158
FIGURE 34NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT158
TABLE 91NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY,
2020–2027 (USD BILLION)159
TABLE 92NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)159
TABLE 93NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT,
2020–2027 (USD MILLION)159
TABLE 94NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION)160
TABLE 95NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)161
TABLE 96NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION)162
TABLE 97NORTH AMERICA: HOME HEALTHCARE MARKET, BY SERVICE,
2020–2027 (USD MILLION)162
TABLE 98NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION,
2020–2027 (USD MILLION)163
9.2.1US163
9.2.1.1US to dominate North American home healthcare market163
TABLE 99US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD BILLION)164
TABLE 100US: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)165
TABLE 101US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)165
TABLE 102US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)166
TABLE 103US: MOBILITY CARE PRODUCTS MARKET, BY TYPE,
2020–2027 (USD MILLION)167
TABLE 104US: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)167
TABLE 105US: HOME HEALTHCARE MARKET, BY INDICATION,
2020–2027 (USD MILLION)168
9.2.2CANADA168
9.2.2.1Rising geriatric population to drive market growth168
TABLE 106CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)169
TABLE 107CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)169
TABLE 108CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)170
TABLE 109CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 110CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 111CANADA: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)172
TABLE 112CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)173
9.3EUROPE173
TABLE 113EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD BILLION)174
TABLE 114EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)174
TABLE 115EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)175
TABLE 116EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)175
TABLE 117EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 118EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)177
TABLE 119EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)177
TABLE 120EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)178
9.3.1GERMANY178
9.3.1.1Germany to retain market leadership in Europe178
TABLE 121GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)179
TABLE 122GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)179
TABLE 123GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)180
TABLE 124GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 125GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)182
TABLE 126GERMANY: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)182
TABLE 127GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)183
9.3.2UK183
9.3.2.1Rising burden of chronic diseases to boost market growth183
TABLE 128UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)184
TABLE 129UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)184
TABLE 130UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)185
TABLE 131UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)186
TABLE 132UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)187
TABLE 133UK: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)187
TABLE 134UK: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)188
9.3.3FRANCE188
9.3.3.1Government support and initiatives taken by market players to boost market188
TABLE 135FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)189
TABLE 136FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)189
TABLE 137FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)190
TABLE 138FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)191
TABLE 139FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)192
TABLE 140FRANCE: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)192
TABLE 141FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)193
9.3.4ITALY193
9.3.4.1Rising geriatric population and favorable government policy to drive market growth193
TABLE 142ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)194
TABLE 143ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)194
TABLE 144ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)195
TABLE 145ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)196
TABLE 146ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)197
TABLE 147ITALY: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)197
TABLE 148ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)198
9.3.5SPAIN198
9.3.5.1Rising geriatric population and incidence of chronic conditions to drive market growth198
TABLE 149SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)199
TABLE 150SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)199
TABLE 151SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)200
TABLE 152SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)201
TABLE 153SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)202
TABLE 154SPAIN: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)202
TABLE 155SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)203
9.3.6REST OF EUROPE203
TABLE 156ROE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)204
TABLE 157ROE: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)204
TABLE 158ROE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)205
TABLE 159ROE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)206
TABLE 160ROE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)207
TABLE 161ROE: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)207
TABLE 162ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)208
9.4ASIA PACIFIC208
FIGURE 35APAC: HOME HEALTHCARE MARKET SNAPSHOT209
TABLE 163ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2020–2027 (USD BILLION)210
TABLE 164ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)210
TABLE 165ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)210
TABLE 166ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)211
TABLE 167ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)212
TABLE 168ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)213
TABLE 169ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)213
TABLE 170ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)214
 
9.4.1JAPAN214
9.4.1.1Japan to command largest share of APAC market214
TABLE 171JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)215
TABLE 172JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)215
TABLE 173JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)216
TABLE 174JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)217
TABLE 175JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)218
TABLE 176JAPAN: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)218
TABLE 177JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)219
9.4.2CHINA219
9.4.2.1Healthcare development and reforms to drive market growth219
TABLE 178CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)220
TABLE 179CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)220
TABLE 180CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)221
TABLE 181CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)222
TABLE 182CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)223
TABLE 183CHINA: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)223
TABLE 184CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)224
9.4.3INDIA224
9.4.3.1Increasing target patient population to drive market224
TABLE 185INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)225
TABLE 186INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)225
TABLE 187INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)226
TABLE 188INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)227
TABLE 189INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)228
TABLE 190INDIA: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)228
TABLE 191INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)229
9.4.4REST OF ASIA PACIFIC229
TABLE 192ROAPAC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)230
TABLE 193ROAPAC: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)230
TABLE 194ROAPAC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)231
TABLE 195ROAPAC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)232
TABLE 196ROAPAC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)233
TABLE 197ROAPAC: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)233
TABLE 198ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)234
9.5REST OF THE WORLD234
TABLE 199ROW: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD BILLION)235
TABLE 200ROW: HOME HEALTHCARE MARKET, BY PRODUCT, 2020–2027 (USD MILLION)236
TABLE 201ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)236
TABLE 202ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)237
TABLE 203ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION)238
TABLE 204ROW: HOME HEALTHCARE MARKET, BY SERVICE, 2020–2027 (USD MILLION)238
TABLE 205ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2020–2027 (USD MILLION)239
10COMPETITIVE LANDSCAPE240
10.1OVERVIEW240
10.2KEY STRATEGIES ADOPTED BY PLAYERS/RIGHT TO WIN240
TABLE 206OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES240
10.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS241
FIGURE 36REVENUE SHARE ANALYSIS OF TOP PLAYERS241
10.4MARKET SHARE ANALYSIS242
FIGURE 37SLEEP APNEA THERAPEUTIC DEVICES MARKET SHARE ANALYSIS,
BY KEY PLAYER (2021)242
FIGURE 38BLOOD GLUCOSE MONITORS MARKET SHARE ANALYSIS,
BY KEY PLAYER (2021)243
10.5COMPANY EVALUATION QUADRANT (2021)244
10.5.1STARS244
10.5.2EMERGING LEADERS244
10.5.3PERVASIVE PLAYERS244
10.5.4PARTICIPANTS244
FIGURE 39HOME HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT, 2021245
10.6COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)246
10.6.1PROGRESSIVE COMPANIES246
10.6.2STARTING BLOCKS246
10.6.3RESPONSIVE COMPANIES246
10.6.4DYNAMIC COMPANIES246
FIGURE 40HOME HEALTHCARE MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021247
10.7COMPETITIVE BENCHMARKING248
FIGURE 41PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS248
TABLE 207HOME HEALTHCARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS248
TABLE 208PRODUCT FOOTPRINT OF KEY PLAYERS249
TABLE 209REGIONAL FOOTPRINT OF KEY PLAYERS249
TABLE 210HOME HEALTHCARE MARKET: DETAILED LIST OF KEY START-UPS/SMES250
10.8COMPETITIVE SCENARIO251
10.8.1PRODUCT LAUNCHES251
TABLE 211KEY PRODUCT LAUNCHES & REGULATORY APPROVALS251
10.8.2DEALS252
TABLE 212KEY DEALS252
10.8.3OTHER DEVELOPMENTS252
TABLE 213OTHER KEY DEVELOPMENTS, JANUARY 2019–OCTOBER 2022252
11COMPANY PROFILES253
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*